Diametric Capital’s Eton Pharmaceutcials ETON Stock Holding History

Diametric Capital’s Portfolio ETON Stock Details ETON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.65M	Sell	73,101 -83,825	-53%	-$2.46M	0.28%	58
2026 Q1	$3.87M	Sell	156,926 -36,229	-19%	-$634K	1.01%	14
2025 Q4	$3.27M	Buy	193,155 +93,846	+94%	+$1.65M	0.88%	18
2025 Q3	$2.16M	Buy	99,309 +14,451	+17%	+$240K	0.8%	22
2025 Q2	$1.21M	Buy	84,858 +65,261	+333%	+$1.03M	0.65%	36
2025 Q1	$254K	Buy	+19,597	New	+$296K	0.3%	116
2021 Q2	–	Sell	-49,536	Closed	-$363K	–	154
2021 Q1	$363K	Sell	49,536 -2,097	-4%	-$17.9K	0.28%	87
2020 Q4	$420K	Buy	51,633 +20,484	+66%	+$158K	0.33%	90
2020 Q3	$246K	Sell	31,149 -198,670	-86%	-$1.36M	0.18%	100
2020 Q2	$1.25M	Sell	229,819 -222,284	-49%	-$1.1M	0.96%	38
2020 Q1	$1.85M	Buy	+452,103	New	+$2.64M	2.25%	7
2019 Q4	–	Sell	-163,033	Closed	-$1.03M	–	137
2019 Q3	$1.03M	Buy	163,033 +18,540	+13%	+$118K	0.85%	44
2019 Q2	$1.14M	Buy	144,493 +22,620	+19%	+$176K	0.72%	49
2019 Q1	$975K	Buy	121,873 +62,871	+107%	+$437K	0.77%	52
2018 Q4	$361K	Buy	+59,002	New	+$362K	0.28%	83

Other funds holding ETON

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return

NPT

National Philanthropic Trust Jenkintown, Pennsylvania $6.92B AUM 24.7% 1-Year Est. Return

Diametric Capital's ETON Position: Q2 2026 in Review

Diametric Capital reduced its Eton Pharmaceutcials (ETON) stake by 53% in Q2 2026, selling an estimated $2.46M and leaving 73,101 shares worth $2.65M. The position accounts for 0.28% of the portfolio, ranked #58.

Diametric Capital first reported a position in ETON in Q4 2018 and has held it in 15 quarters since. The position peaked at $3.87M in Q1 2026. 165 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

Diametric Capital held 73,101 shares of Eton Pharmaceutcials worth $2.65M as of Q2 2026.
Diametric Capital sold 83,825 Eton Pharmaceutcials shares in Q2 2026, an estimated $2.46M.
Eton Pharmaceutcials made up 0.28% of Diametric Capital's portfolio in Q2 2026, its #58 holding.
Diametric Capital first reported a position in Eton Pharmaceutcials in Q4 2018 and has held it in 15 quarters since.
Diametric Capital's Eton Pharmaceutcials position peaked at $3.87M in Q1 2026.
165 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on Diametric Capital's 13F filing for Q2 2026, filed 14 Aug 2026.